Investigative and Clinical Urology

The Korean Urological Association (대한비뇨의학회)
권호 표지

Development of the Korean-translation of Androgen Deficiency in Aging Males (ADAM) Questionnaire

Androgen Deficiency in Aging Males (ADAM) 설문지의한국어 번역본 개발

Kim, Soo-Woong;Oh, Seung-June;Paick, Jae-Seung;Kim, Sae-Chul
김수웅;오승준;백재승;김세철

  • Published : 20040700
⟨ Previous Next ⟩

Abstract

Purpose: A questionnaire is a mandatory screening tool for the deduction of an androgen deficiency in aging males (ADAM). The aim of this study was to translate the ADAM questionnaire into Korean and validate it linguistically. Materials and Methods: Two native Korean speakers, who were also fluent in English, independently translated the original English version of the ADAM questionnaire into written Korean. A panel, consisting of the aforementioned translators and four urologists, reviewed the translations to form a single acceptable forward translation. Another translator, having never seen the original version, back-translated the first draft into English. The discrepancies between the original form and the first draft of the Korean translation were reviewed by the panel. Cognitive debriefing interviews with five impotent males with low serum total testosterone levels (＜250 ng/dl) were conducted to test the interpretation of the translation. Results: After the forward translation of the ADAM questionnaire, the cultural, linguistic and emotional aspects were discussed, item-by-item, to arrive at a first version. Another bilingual translator then back- translated the first Korean version into English. The panel discussed every discrepancy and decided to modify questions 6 and 8 (second version). Five ADAM patients gave their opinions on the understandability of the translated questionnaire and clarified the questions on a standard form. Through this cognitive debriefing process, the second version was verified as the final Korean version of the ADAM questionnaire, without modifications. Conclusions: The linguistic validation of Korean version of the ADAM questionnaire has been completed, which might be a useful and reasonable screening tool for the detection of androgen deficiency in aging Korean males.

Keywords

References

  1. Werner AA. The male climacteric. J Am Med Assoc 1939;112: 1441-3 https://doi.org/10.1001/jama.1939.02800150013004
  2. Solstad K, Garde K. Middle-aged Danish men's ideas of male climacteric and of the female climacteric. Maturitas 1992;15: 7-16
  3. Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991;73:1016-25 https://doi.org/10.1210/jcem-73-5-1016
  4. Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Morley PM, Stauber PM, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997;46:410-3 https://doi.org/10.1016/S0026-0495(97)90057-3
  5. Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D, et al. Validation of a screening questionnaire for androgen deficiency in aging males. Metabolism 2000;49: 1239-42 https://doi.org/10.1053/meta.2000.8625
  6. Oh SJ, Park HG, Lim SW, Hong SK, Martin ML, Ting BL, et al. Translation and linguistic validation of Korean version of the Incontinence Quality of Life (I-QoL) instrument. J Korean Continence Soc 2002;6:10-23
  7. Kim HY, So HS, Park KS, Jeong SJ, Lee JY, Ryu SB. Female sexual function index (FSFI). Korean J Androl 2002;20:50-6
  8. Morley JE, Kaiser F, Raum WJ, Perry HM 3rd, Flood JF, Jensen J, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 1997;94:7537- 42 https://doi.org/10.1073/pnas.94.14.7537
  9. Korenman SG, Morley JE, Mooradian AD, Davis SS, Kaiser FE, Silver AJ, et al. Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab 1990;71: 963-9 https://doi.org/10.1210/jcem-71-4-963
  10. Nankin HR, Calkins JH. Decreased bioavailable testosterone in aging normal and impotent men. J Clin Endocrinol Metab 1986;63:1418-20 https://doi.org/10.1210/jcem-63-6-1418
  11. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C. A New ‘Aging Male's Symptoms' (AMS) Scale. The Aging Male 1999;2:105-14 https://doi.org/10.3109/13685539909003173
  12. Daig I, Heinemann LA, Kim S, Leungwattanakij S, Badia X, Myon E, et al. The Aging Males' Symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes 2003;1:77 https://doi.org/10.1186/1477-7525-1-77